palbociclib,letrozole
pfizer
['ibrance', 'palbociclib', 'paloma-2', 'breast', 'pfizer']
 announces overall survival results from phase 3 paloma-2 trial of ibrance (palbociclib) for the first-line treatment of er+, her2- metastatic breast cancer #breastcancerresearch #breastcancer #malebreastcancer #asco22 
We are your resource for MEN with breast cancer. Our reach is global and continues to grow daily.  #MaleBreastCancer